Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype

Benutzer: Gast

Titel:: Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype
Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Puente-Marin, Sara ; Dietrich, Fabrícia ; Achenbach, Peter ; Barcenilla, Hugo ; Ludvigsson, Johnny ; Casas, Rosaura
Stichworte:: Immunology ; immunotherapy ; autoantigen ; GAD-alum ; type 1 diabetes ; DR3DQ2 haplotype ; intra-lymphatic treatment ; lymph node
Zeitschriftentitel:: Frontiers in Immunology
Jahr:: 2023
Band / Volume:: 14
Volltext / DOI:: doi:10.3389/fimmu.2023.1112570
Verlag / Institution:: Frontiers Media S.A.
E-ISSN:: 1664-3224
Publikationsdatum:: 02.02.2023
CC-Lizenz:: by, https://creativecommons.org/licenses/by/4.0

BibTeX

Vorkommen: